Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;

P-32 ACCESSIBILITY TO SEQUENTIAL SYSTEMIC TREATMENT AFTER TACE: IMPACT ON SURVIVAL IN A LATIN AMERICAN PROSPECTIVE COHORT FEDERICO PIÑERO; Margarita Anders; Carla Bermúdez; Diego Arufe; Adriana Varón; Ana Palazzo; Jorge Rodríguez; Oscar Beltrán; Patricio Palavecino Rubilar; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Norberto Tamagnone; Hugo Cheinquer; Nicolás Cortés Medina; Juan Ignacio Marín; Estela Manero; Federico Orozco Ganem; Jaime Poniachik; Sebastián Marciano; Virginia Reggiardo; Manuel Mendizabal;

P-34 ALBUMIN-BILIRUBIN GRADE ANALYSIS OF OVERALL SURVIVAL WITH ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA Cristina Cheinquer Coelho Borges; Alexandre de Araújo; Mario Alvares-da-Silva Reis; Rui Weschenfelder; Hugo Cheinquer;